Inhalation Sciences and AstraZeneca have entered into a collaboration to use PreciseInhale for the evaluation of inhaled drugs. PreciseInhale is recognized as exceptionally innovative by several pioneering groups…
A new paper from ISAB and Astra Zeneca shows how DissolvIt simulates the dissolution and absorption of dry powder aerosols in the lung. The paper describes successful in…
A new paper from ISAB and Astra Zeneca shows how DissolvIt simulates the dissolution and absorption of dry powder aerosols in the lung. The paper describes successful in…
Inhalations Sciences AB (ISAB) has signed a purchase order for its dry powder aerosol system PreciseInhale, with one of Europe’s leading inhalation Research Groups. Fredrik Sjövall, ISAB CEO:…
Inhalations Sciences AB (ISAB) has signed a purchase order for its dry powder aerosol system PreciseInhale, with one of Europe’s leading inhalation Research Groups. Fredrik Sjövall, ISAB CEO:…
ISAB is delivering two presentations detailing its nanoparticle research at this year’s SOT: A poster shows how copper and copper oxide nanoparticles dissolve in the lung, co-authored by…
ISAB’s R&D dry powder aerosol system PreciseInhale has been purchased by Dow Chemicals, Chiesi, King’s College London, and produced six patents, with more in the pipeline. For 17…
On February 13 2017 Karolinska Development AB (KDEV) announced it was divesting its shares in ISAB to a new consortium made up of Råsunda Förvaltning AB, Inhalation Sciences`…
On February 13 2017 Karolinska Development AB (KDEV) announced it was divesting its shares in ISAB to a new consortium made up of Råsunda Förvaltning AB, Inhalation Sciences`…
A new nebulizer module for PreciseInhale will combine the popular availability of nebulizer sprays with precision dosing. For the first time researchers will be able to set the…
